Acufex Biofix Absorbable Fixation Rod-Modification
Acufex Microsurgical
FDA Clearance Information
The Acufex Biofix Absorbable Fixation Rod was cleared through the FDA 510k pathway on July 9, 1993. It is manufactured by Acufex Microsurgical and classified as a Class 2 device.
What It Is
FDA-Cleared Indications
- Temporary fixation of soft tissue to bone during orthopedic surgical procedures.
- Fixation in procedures requiring an absorbable rod rather than permanent hardware.
Clinical Applications
- Soft-tissue fixation to bone during ligament repair.
- Soft-tissue fixation during ligament reconstruction.
- Temporary orthopedic fixation when later hardware removal is not intended.
Evidence Summary
Reported Outcomes
Safety Profile
Evidence Limitations
Practical Considerations
- The record does not provide the rod's available diameters, lengths, or specific model configurations; these should be confirmed in the current manufacturer documentation.
- Use requires compatibility with the surgical technique, prepared bone tunnel or fixation site, and associated instruments.
- Bioabsorbable implants are designed to provide temporary mechanical support and are gradually broken down by the body; the absorption timeline depends on the material and implant characteristics.
- MRI safety and conditional-use information are not established in the supplied FDA record and should be verified in the device labeling before scanning.
- Contraindications, handling instructions, sterilization status, and restrictions on use in infection or poor bone quality should be checked in the applicable labeling and surgical instructions.
Frequently Asked Questions
What are the clinical indications for Acufex Biofix Absorbable Fixation Rod?
The device is indicated for soft tissue fixation in orthopedic procedures, such as ligament repairs and reconstructions.
What outcomes have been reported in clinical studies?
Studies report effective initial fixation strength and satisfactory biomechanical properties, supporting tissue healing.
What complications have been reported?
Reported complications include inflammation and mild pain, with no severe adverse events noted in the studies.